Copyright
©The Author(s) 2015.
World J Transplant. Sep 24, 2015; 5(3): 129-136
Published online Sep 24, 2015. doi: 10.5500/wjt.v5.i3.129
Published online Sep 24, 2015. doi: 10.5500/wjt.v5.i3.129
Figure 1 Cumulative incidence of 100-d transplant-related-mortality according to occurrence or not of a cytomegalovirus symptomatic reactivation/end-organ disease (8.
4% ± 4.7% vs 1.7% ± 0.8%; P = 0.047). TRM: transplant-related-mortality; CMV: Cytomegalovirus.
- Citation: Marchesi F, Pimpinelli F, Gumenyuk S, Renzi D, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Ensoli F, Mengarelli A. Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: A single-center study. World J Transplant 2015; 5(3): 129-136
- URL: https://www.wjgnet.com/2220-3230/full/v5/i3/129.htm
- DOI: https://dx.doi.org/10.5500/wjt.v5.i3.129